Pharma tech firms announce global MES partnership
Zenith Technologies and Werum IT Solutions to help improve pharma companies' production performance.
Zenith Technologies and Werum IT Solutions have formed a global partnership to support pharmaceutical companies with the implementation of manufacturing execution system (MES) technology to improve production performance.
The collaboration brings together Werum IT Solution’s MES PAS-X software, which is designed to increase efficiency, improve productivity and meet regulatory requirements during pharmaceutical manufacturing, with Zenith Technologies’ ability to integrate systems and provide on-the-ground automation technical support. The PAS-X software is used by the majority of the world’s top 30 pharmaceutical and biotech companies but also by many regional and mid-sized manufacturers.
The partnership, which was signed at Werum’s headquarters in Lüneburg, Germany, makes Zenith Technologies an Endorsed Service Partner of Werum IT Solutions in both the US and Europe. Zenith Technologies will support Werum customers during all MES implementation phases, delivering comprehensive support and consultancy services that complement Werum’s manufacturing IT solutions.
“We are delighted to partner with Zenith Technologies,” says Torsten Isenberg, Senior Director Services at Werum IT Solutions GmbH. “As an Endorsed Service Partner, Zenith Technologies has the knowledge and experience required to be part of our PAS-X service partner program. Our main objective is to ensure a high level of support for our customers through reliable, experienced and certified partners.”
Brendan O’ Regan, chairman and founder, Zenith Technologies, adds: “Given our combined expertise in automation and the similarities in our customer base, the collaboration represents a strategic move for both companies. By combining Werum’s MES technology with our technical implementation experience, we can provide customers with a high quality of service, training and local level support, helping them to remain both compliant and competitive. We are continually investing in training and working together with Werum and other solution providers to ensure we stay ahead with the latest technology.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance